cancerGRACE

GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

Health EN ↓ 244 episodes

In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis. For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums

Author

cancerGRACE

Category

Health

Podcast website

cancerGRACE.org

Latest episode

May 13, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Trials in EGFR Mutated NSCLC: Mariposa2 and Laura- 2024 Leading Developments in Lung Cancer 12.02.2025

Drs. Desai and Abu Rous discuss trial date from Mariposa2 and Laura as presented at 2024 ASCO, and the implications in treating EGFR+ NSCLC.

Tarlatamab for Extensive Stage Small Cell Lung Cancer- 2024 Leading Developments in Lung Cancer 07.02.2025

Drs. Desai and Abu Rous discuss using tarlatamab in treating extensive stage small cell lung cancer.

Staging Skin Cancer 30.01.2025

Dr. Vernon Sondak discusses what factors go into the decision on staging skin cancer, including the various guidelines that different doctors may use.

Advances in Thyroid Cancer Treatment 29.08.2024

Drs. Patel, Sheth, and Weiss discuss emerging data and advances in thyroid cancer treatment.

Incurable HPV Negative Head and Neck Cancer 21.08.2024

Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in incurable HPV negative head and neck cancer.

Recurrent/Metastatic HPV Positive Head and Neck Cancer 14.08.2024

Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in recurrent/metastatic HPV positive head and neck cancer.

Curable HPV Negative Head and Neck Cancer 07.08.2024

Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV negative head and neck cancer.

Curable HPV Positive Head and Neck Cancer 30.07.2024

Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV positive head and neck cancer.

What is a Bone Marrow Transplant? 12.06.2024

Dr. Marco Ruiz explains the concept of bone marrow transplant, and how it is used in treating blood cancers.

Q&A: Do People in Rural Communities Have Equal Access to Treatment Options? 10.06.2024

Drs. Goodman, Phillips, Taneja, and Rajeeve discuss whether a patient's location can affect the treatments they can access and their overall prognosis.

Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine? 05.06.2024

Drs. Goodman, Phillips, Taneja, and Rajeeve discuss how to navigate treatment and Covid vaccination.

Bispecific Antibodies in Myeloma: Approvals and Clinical Trials 31.05.2024

Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials.

Curative Strategies for Patients with Smoldering Multiple Myeloma 23.05.2024

Dr. Alankrita Taneja examines data from the CESAR trial, and discusses curative strategies for Smoldering Multiple Myeloma.

Management of Bispecific Antibodies Side Effects 17.05.2024

Dr. Sridevi Rajeeve discusses possible side effects from bispecific antibodies, and how to manage them.

Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data 10.05.2024

Dr. Sridevi Rajeeve discusses the unprecedented response rates in patients treated with teclistamab, talquetamab, and elranatamab, as well as their clinical trial data.

Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma 03.05.2024

Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL)

Barriers to Biomarker Testing: Cost and Insurance 27.04.2024

Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.

Barriers to Biomarker Testing: Ordering Tests 20.04.2024

Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC

The Adaura Trial: The Effect on EGFR+ Treatment 15.04.2024

Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.

Biomarker Driven Therapy for NSCLC 13.04.2024

Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.

Current Recommendations and Best Practices for Biomarker Testing 11.04.2024

Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.

The Importance of Biomarker Testing: What is Liquid Biopsy? 09.04.2024

Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.

Biomarkers in NSCLC 09.04.2024

Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.

Key Points from the Adaura Trial: Osimertinib 30.11.2023

Dr. Joshua Reuss examines important details learned during the ADAURA trial, including overall survival, reduced risk of brain mets, and side effects.

Biomarkers in NSCLC 23.11.2023

Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.

Listen to the GRACEcast - Discussions with the Global Resource for Advancing Cancer Education podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.